Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa
Nombuyiselo J. Mofokeng(University of the Free State), Philippa C. Matthews(University College London Hospitals NHS Foundation Trust), Leane Badenhorst(University of the Free State), Sabeehah Vawda(University of the Free State), Molefi Daniel Morobadi(University of the Free State), Dominique Goedhals(University of the Free State), Veronica Miller(University of California, Berkeley), Dan Wu(Shanghai Children's Medical Center), Jantjie Taljaard(Stellenbosch University), Cloete van Vuuren(University of the Free State), Joseph D. Tucker(University of North Carolina at Chapel Hill), Tongai Maponga(Stellenbosch University), Janet Seeley(Africa Health Research Institute), Wolfgang Preiser(National Health Laboratory Service), Su Wang(Rutgers, The State University of New Jersey), Susan Hugo(Stellenbosch University), Christo Van Rensburg(Stellenbosch University), Marije Van Schalkwyk
Cited by 6
Related Papers
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
|New England Journal of Medicine|2003|4.8k
Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
|Cell stem cell|2016|565
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
|Nature Medicine|2021|564
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
|The Lancet Respiratory Medicine|2021|434